SRPT Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 1203 min ago

@ $119.15

Išleistas: 17 birž. 2024 @ 20:27

Grąža: -1.41%

Ankstesnis signalas: birž. 14 - 21:58

Ankstesnis signalas: Pardavimas

Grąža: -1.65 %

Live Chart Being Loaded With Signals

Commentary (18 birž. 2024 @ 16:30):
Our systems believe the stock currently is undervalued by -0.52% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	8 989
Vidutinė apimtis	1.32M
Rinkos kapitalizacija	11.10B
EPS	$0.380 ( Q1 \| 2024-05-01 )
Kita pelno data	( $-0.0500 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	273.19 (Sector) 42.63 (Industry) 24.32
ATR14	$4.93 (4.22%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO -0.44%

ABIO 2.17%

ABOS -0.40%

ABSI 0.55%

ABUS 0.33%

ABVX -0.22%

ACAD 0.54%

ACER -17.95%

ACET 0.00%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP 0.33%

ADGI 0.87%

ADIL 1.57%

ADMA 0.19%

ADPT -0.96%

ADTX -1.27%

ADVM -0.55%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -1.89%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 3.34%

ALEC 0.44%

ALGS -0.25%

ALKS 0.34%

ALLK -0.85%

ALLO -0.87%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.84%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.14%

ANL 0.61%

ANNX -0.93%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.15%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.32%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR 0.00%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.75%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 2.16%

ATRA -2.26%

ATXI -1.66%

ATXS 0.45%

AUPH -0.36%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.24%

AVTX 4.15%

AVXL -0.13%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.40%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI 1.23%

BCRX -0.24%

BCTX -0.68%

BCTXW 0.00%

BCYC 0.00%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -0.61%

BMEA -0.20%

BMRN 0.19%

BNOX 10.76%

BNTC 2.46%

BNTX 0.19%

BOLD 0.49%

BOLT -0.50%

BPMC 0.28%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.90%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -2.22%

CADL -1.11%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.83%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.19%

CDXS -1.49%

CELC 1.03%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.41%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.95%

CGEN -1.02%

CGON 0.00%

CGTX 1.39%

CHMA -6.00%

CHRS -0.01%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.89%

CLGN 0.30%

CLLS -6.54%

CLNN 6.88%

CLNNW -41.25%

CLRB 0.64%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 1.82%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -1.73%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT 0.10%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU 0.00%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.16%

CRSP 0.51%

CRTX 2.63%

CRVO -1.89%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 3.65%

CTNM -2.94%

CTXR -1.01%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.13%

CYTO -3.23%

DARE 1.19%

DAWN 0.42%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.00%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 4.31%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 3.24%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.50%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.23%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI -0.20%

EXEL -0.30%

EYEG -0.43%

EYEN -0.33%

EYPT 0.00%

FATE 0.42%

FBIO 0.53%

FBIOP 1.09%

FBLG -1.17%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD 0.30%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.76%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.96%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -1.83%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.95%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 11.54%

GOVX 19.82%

GOVXW -24.72%

GPCR 0.94%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.75%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO 0.48%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.66%

HSTO 62.16%

HUMA -0.32%

HUMAW -5.97%

IBRX 0.34%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -0.81%

IMGN 0.02%

IMGO 0.00%

IMMP -1.47%

IMMX -0.49%

IMNM -1.14%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT -1.34%

INAB -0.02%

INBX -0.35%

INCY 0.01%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.05%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -6.11%

IONS -0.37%

IOVA -0.25%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -0.09%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX 0.17%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.57%

KRRO -0.63%

KRTX 0.03%

KRYS 0.24%

KTRA 9.24%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX -0.25%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.97%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.46%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.91%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -1.93%

LQDA -0.23%

LRMR 1.13%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL 3.12%

LYRA -1.26%

MACK 0.00%

MBIO 36.07%

MBRX -4.83%

MCRB -0.88%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.12%

MGNX -3.02%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.05%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.20%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.00%

MNMD 0.53%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.54%

MORF 1.36%

MREO 0.00%

MRKR -4.76%

MRNA -0.99%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS -0.39%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -0.85%

NKTX -1.23%

NLSP 161.29%

NLSPW 8.38%

NMRA 0.53%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 3.43%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL 0.43%

NVAX -1.07%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -3.21%

OCGN 3.37%

OCS -1.09%

OCUL -1.45%

OCUP 0.59%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 8.60%

ONCO 18.31%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -5.03%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX 0.31%

PDSB 0.19%

PEPG 0.70%

PGEN 0.63%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.56%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 0.34%

PRQR -5.29%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 17.86%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.75%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -0.28%

RCKT 0.19%

REGN 0.11%

RENB 0.00%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.26%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.54%

RLAY 0.21%

RLMD 0.00%

RLYB 0.00%

RNA -1.52%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.75%

ROIV 0.28%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.04%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC 0.36%

RVPH 0.00%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.75%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.91%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.55%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.19%

SMMT 0.57%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.63%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.52%

SWTX -1.41%

SYBX -0.63%

SYRS -1.93%

TALS -0.73%

TARA -0.78%

TARS 1.72%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.00%

TFFP -2.05%

TGTX 0.31%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.59%

TNXP 0.00%

TNYA 0.00%

TPST 0.34%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -6.45%

TSVT -0.49%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.53%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.02%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 1.48%

VRPX -11.90%

VRTX -0.06%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 5.86%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.97%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.50%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Murray Dallan	Sell	3 635	Common Stock
2024-04-24	Murray Dallan	Sell	0	Common Stock
2018-03-03	Murray Dallan	Sell	113	Stock Option (Right to buy)
2019-03-05	Murray Dallan	Sell	9 039	Stock Option (Right to buy)
2020-03-04	Murray Dallan	Sell	8 821	Stock Option (Right to buy)

INSIDER POWER
15.03
Last 99 transactions
Buy: 338 836 \| Sell: 333 998

Koreliacija (AI algo v.1.1b): Undervalued: -0.52% $116.23 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.89 (strong negative)

Trumpas: -0.91 (very strong negative)

Signal:(33) Neutral

Sarepta Therapeutics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
VIA	0.832

10 Labiausiai neigiamai susiję koreliacijos
WINT	-0.863
EJH	-0.838
UTRS	-0.821
HQI	-0.82
PLL	-0.819
TENX	-0.815
GLBS	-0.813
BKYI	-0.809
NMRD	-0.807
VRM	-0.806

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Sarepta Therapeutics Inc Koreliacija - Valiuta/Žaliavos

0.79
( moderate )

0.54
( weak )

-0.75
( moderate negative )

-0.09
( neutral )

0.05
( neutral )

-0.57
( weak negative )

Sarepta Therapeutics Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$1.24B
Bruto pelnas:	$1.09B (87.91 %)
EPS:	$-5.80

FY	2023
Pajamos:	$1.24B
Bruto pelnas:	$1.09B (87.91 %)
EPS:	$-5.80

FY	2022
Pajamos:	$933.01M
Bruto pelnas:	$793.02M (85.00 %)
EPS:	$-8.03

FY	2021
Pajamos:	$701.89M
Bruto pelnas:	$604.84M (86.17 %)
EPS:	$-5.15

Financial Reports:

No articles found.

Sarepta Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.